Answers are grounded in this paper and cite their sources.
Drug repurposing and development to meet the threat of antimicrobial resistance can be costly and time-consuming, but AI models may be able to help. In this News and Perspectives article, JMIR Correspondent Sara Novak reports on recent research training models to identify candidate drugs to treat resistant infections.
No takes yet. Share an insight, caveat, or question.
Sara Novak (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: